Lurasidone for the Treatment of Bipolar Depression: An Evidence-Based Review

Neuropsychiatric Disease and Treatment
doi 10.2147/ndt.s50961
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Comparative Efficacy and Tolerability of Lurasidone for the Management of Bipolar Depression: A Systematic Review and Network Meta-Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

An Evidence-Based Review of Fremanezumab for the Treatment of Migraine

Pain and Therapy
NeurologyAnesthesiologyPain Medicine
2020English

Lurasidone as Adjunctive Therapy With Lithium or Valproate for the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study

American Journal of Psychiatry
PsychiatryMental Health
2014English

Pediatric Depression: An Evidence-Based Update on Treatment Interventions

Current Psychiatry Reports
PsychiatryMental Health
2013English

108 Lurasidone in Children and Adolescents With Bipolar Depression Presenting With Mixed Features

CNS Spectrums
PsychiatryMental HealthNeurology
2018English

Pharmacological Treatment of Bipolar Depression

Advances in Psychiatric Treatment
2014English

Pharmacotherapy for the Treatment of Acute Bipolar II Depression

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2011English

Nilotinib for the Treatment of Chronic Myeloid Leukemia: An Evidence-Based Review

Core Evidence
MedicineReviewsReferencesPharmacology
2009English

Qualitative Study of Patients’ Preferences for Bipolar Depression Treatment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy